Rhythm Pharmaceuticals
Develops precision medicines for rare neuroendocrine and obesity diseases.
Company facts
- Founded
- 2008
- Employees
- 414
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: RYTM
- Subsidiaries
- Xinvento, Rhythm Pharmaceuticals Limited, Rhythm Securities Corp, Rhythm Pharmaceuticals Netherlands B.V., Rhythm Pharmaceuticals UK Limited, Rhythm Pharmaceuticals France SAS, Rhythm Pharmaceuticals Italy S.r.L., Rhythm Pharmaceuticals Canada Inc.